Clinical Trial Update: Study to Investigate the Effect of Inhaled Tiotropium Bromide on Neurokinin-A Induced Bronchoconstriction in Patients With Mild-to-moderate Asthma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating inhaled tiotropium bromide for neurokinin-A–induced bronchoconstriction in mild-to-moderate asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• tiotropium bromide (tiotropium)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Asthma | Phase 2 | Status: COMPLETED